Related Experiment Video

Updated: May 4, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K

Recommendations for management of patients with neuroendocrine liver metastases

Andrea Frilling1, Irvin M Modlin2, Mark Kidd2

  • 1Imperial College London, London, UK.

The Lancet. Oncology
|January 4, 2014
PubMed

Insights

This review provides evidence-based recommendations for managing neuroendocrine liver metastases, addressing the lack of rigorous trial data. It synthesizes expert consensus to guide clinical practice and future research endeavors.

Area of Science:

  • Oncology
  • Hepatology
  • Interventional Radiology

Background:

  • Neuroendocrine liver metastases have diverse management strategies, including surgery, ablation, and systemic therapies.
  • Current literature is limited by a lack of biological, molecular, and genomic data, and insufficient evidence from rigorous clinical trials.
  • This limits the validity of many existing management guidelines.

Purpose of the Study:

  • To review current management approaches for neuroendocrine liver metastases.
  • To assess the evidence base for existing treatment decisions.
  • To develop internationally acceptable clinical practice recommendations and propose future research directions.

Main Methods:

  • An international conference convened 15 expert working groups.
  • Evidence-based assessments were prepared for specific clinical questions.
  • An independent jury derived final recommendations based on expert group reports.

Main Results:

  • The review synthesizes expert consensus on neuroendocrine liver metastases management.
  • Evidence-based clinical statements were formulated.
  • Recommendations for future clinical and research endeavors were established.

Conclusions:

  • There is a need for improved evidence to guide the management of neuroendocrine liver metastases.
  • Consensus-based recommendations can support current clinical practice.
  • Further research is crucial to advance treatment strategies for this condition.

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

1.4K

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549